7 Factors Making Chiropractic Care Ever Relevant

Chiropractic care has been around for about a century, and it’s not going anywhere anytime soon. Many factors make chiropractic care still relevant today, especially in Poway, California. Chiropractors can help with problems in other body parts, like headaches or sciatica. Besides, they’re more affordable than most doctors. The treatment is also less painful than traditional medical treatments, so patients don’t have to worry about side effects from drugs or surgery. What makes chiropractic care relevant even today?

1.   Reduces Reliance on Opioid Pain Relievers

One of the most critical factors that make chiropractic care relevant is its ability to help reduce reliance on opioid pain relievers. A large percentage of the population is now addicted or dependent on opioids, which has led to an epidemic of overdoses and deaths. Chiropractic care can help relieve pain without the need for such potent and addictive drugs. In some cases, chiropractic care may even eliminate the need for opioids.

2.   Prevents and Treats Chronic Conditions

Chiropractic care is also very effective in preventing and treating chronic conditions such as back pain, neck pain, and headaches. It can help improve mobility and function and reduce the need for medication. Chiropractic care is a holistic approach that can address the root cause of these conditions rather than simply treating the symptoms.

3.   Improves Neck Pain and Headaches

Neck pain and headaches are two of the most common complaints. Chiropractic care can help relieve both of these problems, and it’s one of the most effective treatments for neck pain and headaches. It can help to restore proper alignment of the spine and improve function. It also reduces or eliminates the pain and headaches.

4.   Helps Reduce Stress

Chiropractic care can also help to reduce stress. When the body is in a state of stress, it can lead to many health problems. Chiropractic care can help restore balance and harmony to the body, which can help to reduce stress levels. It can also help to improve mood and increase energy levels.

5.   Eases Headache Symptoms

Chiropractic care can also help to ease headache symptoms. In some cases, chiropractic care may be able to eliminate headaches. It can help to restore proper alignment of the spine and improve function. It also reduces or eliminates the pain and headaches.

6.   Safe and Effective for All Ages

It is a non-invasive treatment that is gentle and painless. It can treat people of all ages, from newborns to seniors. Chiropractic care is a holistic approach that can address the root cause of problems rather than simply treating the symptoms.

7.   Helps Improve Posture

Chiropractic care can also help to improve posture. Poor posture can lead to various health problems, including back pain, neck pain, and headaches. Chiropractic care can help restore proper alignment of the spine and improve function. It also reduces or eliminates the pain and headaches.

Chiropractic care has been around for about a century, and it’s not going anywhere anytime soon. Many factors make chiropractic care still relevant to this day. Chiropractors can help with problems in other body parts, like headaches or sciatica. One of the most critical factors that make chiropractic care relevant is its ability to help reduce reliance on opioid pain relievers.

This is only for your information, kindly take the advice of your doctor for medicines, exercises and so on.   

https://gscrochetdesigns.blogspot.com. one can see my crochet creations  
https://gseasyrecipes.blogspot.com. feel free to view for easy, simple and healthy recipes    
https://kneereplacement-stickclub.blogspot.com. for info on knee replacement

 

 

Study reveals how oral antiviral drug works to attack SARS-CoV-2 virus

A University of Alberta virology lab has uncovered how an oral antiviral drug works to attack the SARS-CoV-2 virus, in findings published May 10 in the Journal of Biological Chemistry.

The researchers demonstrated the underlying mechanism of action by which the antiviral drug molnupiravir changes the viral genome, a process known as excessive mutagenesis or “error catastrophe.”

The polymerase, or replication engine of the virus, mistakes molnupiravir molecules for the natural building blocks required for viral genome replication and mixes them in. It causes the polymerase to make sloppy copies—nonsense genomes that are useless and not viable.”

Matthias Götte, Professor and Chair of Department of Medical Microbiology & Immunology in the Faculty of Medicine & Dentistry and Member of Li Ka Shing Institute of Virology

Molnupiravir is currently in Phase 3 human clinical trials, which are expected to report preliminary data by the end of June. Phase 2 trial results recently revealed that the drug eliminated SARS-CoV-2 infectivity in newly diagnosed patients after five days of treatment.

The drug is taken as a pill, making it much easier to administer than other approved treatments such as remdesivir or monoclonal antibodies, which must be given intravenously. It has not yet been shown to be effective in treating hospitalized COVID-19 patients with advanced disease, so current trials are focused on determining how well it works for newly diagnosed patients. It is hoped the drug could also be used as a preventive measure to protect household members against infection.

“Molnupiravir is one of the few compounds under investigation that is orally available,” Götte said. “Data reported so far demonstrate that this drug is well tolerated with no signs of severe side-effects, and it shows an antiviral effect after five days. Whether it can also reduce hospitalizations remains to be seen.”

“Our work to demonstrate that the effect of the drug is indeed mediated by the viral polymerase is reassuring, because if the drug somehow generates mistakes in the virus and you don’t know how it happens, there could be other mechanisms at work that could also harm the cell,” he said. “Still, the safety of the drug for COVID-19 patients remains to be evaluated and monitored."

Another step in the hunt for a weapon against future pandemics

Molnupiravir was first identified as a broad spectrum antiviral at Emory University in Atlanta, Georgia. In 2003 it was developed as a treatment for chronic hepatitis C, but it was dropped due to possible side-effects associated with long-term use. The drug was then tested in humans with influenza, because the course of treatment for flu is much shorter. The focus of testing switched to SARS-CoV-2 after the COVID-19 pandemic emerged. The drug is now being developed in partnership by Merck and Ridgeback Biotherapeutics.

Merck has made deals with five generic drugmakers in India to make molnupiravir, and at least one of them has applied for approval to use it on an emergency basis, as at least 350,000 new infections are diagnosed in that country every day and vaccination levels are low.

Götte and his team previously uncovered the mechanisms of action for remdesivir, a now-approved treatment that inhibits replication of the SARS-CoV-2 virus, and baloxavir, an influenza drug.

Next, they will test molnupiravir’s mechanism of action against the polymerases of some of the other viruses the World Health Organization has identified as having high epidemic potential.

“All are recognized as emerging pathogens where we need to develop countermeasures,” Götte said. “We need to be prepared with broad-spectrum antivirals that can serve as a first line of defence.”

“Even once vaccines are developed, we can’t get them into all the arms at once,” he said. “To really fight outbreaks and epidemics, one tool is unlikely to be sufficient.”

This is only for your information, kindly take the advice of your doctor for medicines, exercises and so on.     

https://gscrochetdesigns.blogspot.com. one can see my crochet creations  
https://gseasyrecipes.blogspot.com. feel free to view for easy, simple and healthy recipes    
https://kneereplacement-stickclub.blogspot.com. for info on knee replacement